Fig. 4From: Efficacy and safety of blood derivatives therapy in Alzheimer’s disease: a systematic review and meta-analysisa Forest plots of all-cause discontinuation rates (7 comparisons, n = 845). b Forest plots of adverse events (8 comparisons, n = 1142)Back to article page